Evolution of Virulence in Emerging Epidemics

Theory predicts that selection for pathogen virulence and horizontal transmission is highest at the onset of an epidemic but decreases thereafter, as the epidemic depletes the pool of susceptible hosts. We tested this prediction by tracking the competition between the latent bacteriophage λ and its virulent mutant λcI857 throughout experimental epidemics taking place in continuous cultures of Escherichia coli. As expected, the virulent λcI857 is strongly favored in the early stage of the epidemic, but loses competition with the latent virus as prevalence increases. We show that the observed transient selection for virulence and horizontal transmission can be fully explained within the framework of evolutionary epidemiology theory. This experimental validation of our predictions is a key step towards a predictive theory for the evolution of virulence in emerging infectious diseases.

[1]  M. Iturriza-Gómara,et al.  Inter-seasonal diversity of norovirus genotypes: Emergence and selection of virus variants , 2007, Archives of Virology.

[2]  Eric J. Arts,et al.  Changes in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression , 2005, Journal of Virology.

[3]  A. Panet,et al.  The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1. , 2002, Journal of neurovirology.

[4]  Kim Sneppen,et al.  Why Do Phage Play Dice? , 2009, Journal of Virology.

[5]  S. Ellner,et al.  Rapid evolution drives ecological dynamics in a predator–prey system , 2003, Nature.

[6]  Roland R. Regoes,et al.  Epidemiological and clinical consequences of within-host evolution. , 2011, Trends in microbiology.

[7]  F. Weissing,et al.  Inhibition of Superinfection and the Evolution of Viral Latency , 2010, Journal of Virology.

[8]  P. Rainey,et al.  TUNING A GENETIC SWITCH: EXPERIMENTAL EVOLUTION AND NATURAL VARIATION OF PROPHAGE INDUCTION , 2009, Evolution; international journal of organic evolution.

[9]  Varun Garg,et al.  A Viral Dynamic Model for Treatment Regimens with Direct-acting Antivirals for Chronic Hepatitis C Infection , 2012, PLoS Comput. Biol..

[10]  E. Arts,et al.  Is HIV-1 evolving to a less virulent form in humans? , 2007, Nature Reviews Microbiology.

[11]  Marco J. Morelli,et al.  Beyond the Consensus: Dissecting Within-Host Viral Population Diversity of Foot-and-Mouth Disease Virus by Using Next-Generation Genome Sequencing , 2010, Journal of Virology.

[12]  Martin A. Nowak,et al.  Superinfection and the evolution of parasite virulence , 1994, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[13]  Riccardo Pansini,et al.  Virulence and competitive ability in genetically diverse malaria infections. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Maurice W. Sabelis,et al.  The Dynamics of Multiple Infection and the Evolution of Virulence , 1995, The American Naturalist.

[15]  T. Day,et al.  A General Theory for the Evolutionary Dynamics of Virulence , 2004, The American Naturalist.

[16]  K. Andersen,et al.  Are growth rates of Escherichia coli in batch cultures limited by respiration? , 1980, Journal of bacteriology.

[17]  J. McVernon.  Adaptive Dynamics of Infectious Diseases: In Pursuit of Virulence Management. Eds. U. Dieckmann, J. A. J. Metz, M. W. Sabelis and K. Sigmund. Cambridge: Cambridge University Press, 2002. Pp. 532, £50.00. ISBN 0-521-78165-5. , 2004, Epidemiology and Infection.

[18]  I. Wang,et al.  Lysis Timing and Bacteriophage Fitness , 2006, Genetics.

[19]  Jean Sippy,et al.  Decision Making at a Subcellular Level Determines the Outcome of Bacteriophage Infection , 2010, Cell.

[20]  Benjamin M Bolker,et al.  Transient virulence of emerging pathogens , 2010, Journal of The Royal Society Interface.

[21]  B. Berkhout,et al.  Retroviral superinfection resistance , 2005, Retrovirology.

[22]  M. Nowak,et al.  Competition-colonization dynamics in an RNA virus , 2010, Proceedings of the National Academy of Sciences.

[23]  J. Clément,et al.  Genetic study of a membrane protein: DNA sequence alterations due to 17 lamB point mutations affecting adsorption of phage lambda. , 1983, The EMBO journal.

[24]  Sylvain Gandon,et al.  Insights from Price's equation into evolutionary epidemiology , 2006, Disease Evolution: Models, Concepts, and Data Analyses.

[25]  Steven A. Frank,et al.  Models of Parasite Virulence , 1996, The Quarterly Review of Biology.

[26]  J. W. Little,et al.  Robustness of a gene regulatory circuit , 1999, The EMBO journal.

[27]  R. May,et al.  The evolution of virulence in parasites and pathogens: reconciliation between two competing hypotheses. , 1994, Journal of theoretical biology.

[28]  D. Pfennig,et al.  Genetic details, optimization and phage life histories. , 2004, Trends in ecology & evolution.

[29]  J. Bull,et al.  Invasion thresholds and the evolution of nonequilibrium virulence , 2008, Evolutionary applications.

[30]  A. Cascio,et al.  Heterogeneity and Temporal Dynamics of Evolution of G1 Human Rotaviruses in a Settled Population , 2006, Journal of Virology.

[31]  O. Pybus,et al.  Unifying the Epidemiological and Evolutionary Dynamics of Pathogens , 2004, Science.

[32]  J. Drake,et al.  Rates of spontaneous mutation. , 1998, Genetics.

[33]  H. Wichman,et al.  Evolutionary Feedback Mediated through Population Density, Illustrated with Viruses in Chemostats , 2005, The American Naturalist.

[34]  L. A. Sepúlveda,et al.  Lysogen stability is determined by the frequency of activity bursts from the fate-determining gene , 2010, Molecular systems biology.

[35]  D. Dykhuizen,et al.  4. EXPERIMENTAL EVOLUTION FROM THE BOTTOM UP , 2009 .

[36]  A. Bailone,et al.  Isolation of ultravirulent mutants of phage λ , 1978 .

[37]  J. Bull,et al.  Optimality models of phage life history and parallels in disease evolution. , 2006, Journal of theoretical biology.

[38]  S. Ellner,et al.  Rapid evolution and the convergence of ecological and evolutionary time , 2005 .

[39]  Troy Day,et al.  The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy , 2011, Proceedings of the National Academy of Sciences.

[40]  Drew Endy,et al.  Determination of cell fate selection during phage lambda infection , 2008, Proceedings of the National Academy of Sciences.

[41]  Jeffrey E. Barrick,et al.  Repeatability and Contingency in the Evolution of a Key Innovation in Phage Lambda , 2012, Science.

[42]  Joshua S. Weitz,et al.  To Lyse or Not to Lyse: Transient-Mediated Stochastic Fate Determination in Cells Infected by Bacteriophages , 2011, PLoS Comput. Biol..

[43]  J. Northrop.  Appearance of Virulent Bacteriophages in Lysogenic E. coli Cultures after Prolonged Growth in the Presence of Triethylenemelamine , 1968, The Journal of general physiology.

[44]  R. Lenski,et al.  EPISTATIC INTERACTIONS CAN LOWER THE COST OF RESISTANCE TO MULTIPLE CONSUMERS , 1999, Evolution; international journal of organic evolution.

[45]  M A Nowak,et al.  Superinfection and the evolution of parasite virulence. , 1994, Proceedings. Biological sciences.

[46]  T. Garland,et al.  Experimental Evolution: Concepts, Methods, and Applications of Selection Experiments , 2009 .

[47]  Tyler J VanderWeele,et al.  Statistical Applications in Genetics and Molecular Biology Epistatic Interactions , 2011 .

[48]  S. Gandon,et al.  Applying population-genetic models in theoretical evolutionary epidemiology. , 2007, Ecology letters.

[49]  I. Wang,et al.  Bacteriophage Adsorption Rate and Optimal Lysis Time , 2008, Genetics.

[50]  S. Gandon,et al.  The evolutionary epidemiology of vaccination , 2007, Journal of The Royal Society Interface.

[51]  F. M. Stewart,et al.  The population biology of bacterial viruses: why be temperate. , 1984, Theoretical Population Biology.

[52]  Gavin J. D. Smith,et al.  Long-term evolution and transmission dynamics of swine influenza A virus , 2011, Nature.

[53]  L. Lin,et al.  Increased reproductive fitness of Escherichia coli lambda lysogens , 1977, Journal of virology.

[54]  W. Sly,et al.  Host survival following infection with or induction of bacteriophage lambda mutants. , 1968, Virology.